Macek Jilkova, Z.;                     Aspord, C.;                     Decaens, T.    
        Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554. Cancers 2020, 12, 2673.
    https://doi.org/10.3390/cancers12092673
    AMA Style
    
                                Macek Jilkova Z,                                 Aspord C,                                 Decaens T.        
                Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554. Cancers. 2020; 12(9):2673.
        https://doi.org/10.3390/cancers12092673
    
    Chicago/Turabian Style
    
                                Macek Jilkova, Zuzana,                                 Caroline Aspord,                                 and Thomas Decaens.        
                2020. "Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554" Cancers 12, no. 9: 2673.
        https://doi.org/10.3390/cancers12092673
    
    APA Style
    
                                Macek Jilkova, Z.,                                 Aspord, C.,                                 & Decaens, T.        
        
        (2020). Reply to Comment on “Jilkova, Z.M.; et al. Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges” Cancers 2019, 11, 1554. Cancers, 12(9), 2673.
        https://doi.org/10.3390/cancers12092673